Growth in diagnostic manufacturing is not only about developing better products or reaching more markets. As a diagnostics company expands its product portfolio, manufacturing capabilities, and geographic presence, every stage of the production process needs to support that growth. Packaging is one of the areas that can become increasingly important as volumes and product complexity increase.
Molbio Diagnostics is a useful example of this broader industry trend. The company describes itself as a point-of-care diagnostics company focused on making accurate, rapid, and cost-effective healthcare technologies more accessible. Its flagship Truenat platform is a portable, battery-operated real-time PCR system designed to support decentralized molecular diagnostics.
For growing diagnostic manufacturers, the question is not simply whether packaging can handle today’s requirements, but whether the existing infrastructure can adapt to tomorrow’s. This is where scalable packaging infrastructure and packaging automation become important considerations.
Molbio’s Truenat platform has evolved into a broader molecular diagnostics ecosystem. The company’s website states that Truenat is patented in more than 100 countries and supports testing for a range of infectious and non-communicable diseases. Its product ecosystem includes the Trueprep AUTO v2 sample preparation device, Truelab real-time quantitative micro-PCR analyzers and disease-specific Truenat assays.
Molbio also maintains manufacturing and quality documentation, including ISO 13485 certification and manufacturing licences covering several products and test kits.
The company’s expansion illustrates an important point for healthcare manufacturers: as products, markets and production requirements become more complex, manufacturing infrastructure needs to remain flexible and scalable.
Diagnostic products can involve different formats, components, pack sizes and handling requirements. For example, Molbio’s Truenat assay documentation describes individually sealed pouches containing components such as micro-PCR chips, reagent tubes, pipette tips and desiccant pouches.
As product portfolios expand, manufacturers may need packaging processes capable of handling:
This makes packaging an important part of the wider manufacturing workflow rather than simply the final step before dispatch.
Manual packaging can be practical for smaller production requirements, but increasing volumes can make repetitive processes more difficult to manage.
Common challenges for growing manufacturers may include:
These are general manufacturing considerations and should not be interpreted as specific problems with Molbio’s existing packaging operations.
For manufacturers experiencing these challenges, evaluating packaging automation solutions can be one way to improve process control and prepare for future production requirements.
A well-designed automated packaging system can help manufacturers create a more consistent and repeatable packaging workflow.
Depending on the application, automated packaging machinery can support areas such as consistent packaging processes, improved production workflow, repeatable operations, controlled product handling, reduced reliance on repetitive manual tasks, better scalability, and more predictable production processes.
The objective is not simply to automate as many activities as possible. The right approach is to identify the processes where automation can provide meaningful operational value and then select equipment around those requirements.
Diagnostic and healthcare manufacturers may need to manage multiple products and packaging configurations. A packaging system designed around only one product format can become restrictive when production requirements change.
Flexible packaging infrastructure can help manufacturers plan for changes involving product formats, pack sizes, production volumes, packaging materials, and product configurations.
This is particularly relevant for businesses that expect their product portfolios or markets to expand. Building flexibility into packaging infrastructure can reduce the risk of creating a production bottleneck later.
Different products require different packaging approaches. Depending on the application, manufacturers may evaluate technologies such as:
The appropriate technology depends on factors such as product characteristics, packaging format, production volume, material requirements, and quality requirements. Not every technology will be suitable for every diagnostic product.
Manufacturers planning their next stage of growth should evaluate packaging infrastructure alongside other production investments.
Useful questions include:
Answering these questions early can help manufacturers identify potential limitations before they become major production constraints.
Molbio Diagnostics’ journey highlights a broader lesson for the healthcare manufacturing sector. Its Truenat platform has expanded across multiple disease applications and has been deployed internationally, while the company continues to maintain a wider portfolio of diagnostic products and manufacturing capabilities.
For diagnostic and pharmaceutical manufacturers, this reinforces the importance of thinking about production infrastructure as an interconnected system.
Manufacturing scalability and packaging scalability should be planned together.
As product portfolios grow, a packaging process that is flexible, consistent, and appropriately automated can become an important part of supporting long-term operational requirements.
At Pactech Solutions, we’ve spent over 30 years helping pharma, FMCG, and industrial manufacturers identify exactly where automation will move the needle, without overhauling a line that’s already working well. Whether it’s a filling bottleneck, an inconsistent seal, or an end-of-line process that’s slowing everyone down, our team can walk your production line with you and point out what’s realistic, what’s not, and what it would take to fix it.
Get in touch with our team for a straightforward conversation about your production line- no pressure, just an honest assessment.
The growth of a diagnostics company involves much more than increasing production. Product variety, packaging requirements, quality expectations and market expansion can all influence how manufacturing infrastructure needs to evolve.
Molbio Diagnostics provides a useful industry example of how innovation, product expansion, manufacturing capabilities, and international reach can increase the importance of scalable infrastructure.
For manufacturers evaluating their next stage of growth, now may be the right time to assess whether their existing packaging process is prepared for future requirements. Pactech Solutions can help businesses evaluate suitable packaging automation technologies based on their products, packaging formats, and operational needs.
